Samuel Kofi Tchum1,2, Samuel Asamoah Sakyi3, Bright Adu4, Fareed Arthur1, Felix Boakye Oppong2, Francis Dzabeng2, Benjamin Amoani5, Thomas Gyan2, Kwaku Poku-Asante2. 1. Department of Biochemistry and Biotechnology, College of Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. 2. Kintampo Health Research Centre, Kintampo-North, Ghana. 3. Department of Molecular Medicine, School of Medicine and Dentistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. 4. Department of Immunology, College of Health Sciences, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Accra, Ghana. 5. Department of Biomedical Sciences, School of Allied Sciences, University of Cape Coast, Cape Coast, Ghana.
Abstract
BACKGROUND: Iron fortification and micronutrient initiatives, specifically, vitamin A, and zinc supplementation are the most cost-effective developmental strategies against malnutrition and health emergencies in pre-school children. Iron-deficiency among pre-school children have been documented, however, studies evaluating the impact of immunoglobulin G (IgG) isotype responses among iron-fortified pre-school children in malaria endemic communities has not been assessed. We evaluated the impact of iron fortification on the IgG responses to GLURP R0, GLURP R2 and MSP3 FVO malaria-specific antigens among pre-school children in malaria endemic areas. METHODS: This community-based, placebo-controlled, double-blinded, cluster-randomized trial study was conducted in Wenchi Municipal and Tain District of Bono Region. The trial was registered at ClinicalTrials.gov-registered trial (Identifier: NCT01001871). Ethical approval was obtained and informed consent were sought from each participant parents/guardian. For the current objective, 871 children aged 6-35 months were screened, from which 435 children receivedsemi-liquid home-made meals mixed with 12.5 mg of iron daily (intervention group), and 436 received micronutrient powder without iron (placebo group) for 5 months. Standardized clinical and epidemiological questionnaires were administered and blood samples taken to measure IgG responses to GLURP R0, GLURP R2 and MSP3 FVO recombinant antigens using the Afro Immunoassay (AIA) protocol. RESULTS:Baseline anthropometry, malaria diagnosis, anaemia and iron status, demographic features and dietary intake were identical among the groups (p > 0.05). After the intervention, there was no significant difference in the IgG response against GLUP R0, GLUP R2 and MSP3 FVO between the iron-containing micronutrient and placebo groups (p > 0.05). The iron-containing micronutrient powder group who were iron-sufficient or iron replete had significantly higher IgG response to GLURP R0 and GLURP R2 compared to iron-deficient and iron-deficiency anaemia in the same group (p < 0.05). The IgG responses to all the three malaria specific antigens were low among children without malaria episode but high among those with two and four episodes due to exposure differences. CONCLUSION: Iron fortification did not influence antibody response against endogenous malaria specific antigens among pre-school children in malaria endemic areas, however, IgG response to malaria specific antigens were high among children with sufficient iron status.
RCT Entities:
BACKGROUND:Iron fortification and micronutrient initiatives, specifically, vitamin A, and zinc supplementation are the most cost-effective developmental strategies against malnutrition and health emergencies in pre-school children. Iron-deficiency among pre-school children have been documented, however, studies evaluating the impact of immunoglobulin G (IgG) isotype responses among iron-fortified pre-school children in malaria endemic communities has not been assessed. We evaluated the impact of iron fortification on the IgG responses to GLURP R0, GLURP R2 and MSP3 FVO malaria-specific antigens among pre-school children in malaria endemic areas. METHODS: This community-based, placebo-controlled, double-blinded, cluster-randomized trial study was conducted in Wenchi Municipal and Tain District of Bono Region. The trial was registered at ClinicalTrials.gov-registered trial (Identifier: NCT01001871). Ethical approval was obtained and informed consent were sought from each participant parents/guardian. For the current objective, 871 children aged 6-35 months were screened, from which 435 children received semi-liquid home-made meals mixed with 12.5 mg of iron daily (intervention group), and 436 received micronutrient powder without iron (placebo group) for 5 months. Standardized clinical and epidemiological questionnaires were administered and blood samples taken to measure IgG responses to GLURP R0, GLURP R2 and MSP3 FVO recombinant antigens using the Afro Immunoassay (AIA) protocol. RESULTS: Baseline anthropometry, malaria diagnosis, anaemia and iron status, demographic features and dietary intake were identical among the groups (p > 0.05). After the intervention, there was no significant difference in the IgG response against GLUP R0, GLUP R2 and MSP3 FVO between the iron-containing micronutrient and placebo groups (p > 0.05). The iron-containing micronutrient powder group who were iron-sufficient or iron replete had significantly higher IgG response to GLURP R0 and GLURP R2 compared to iron-deficient and iron-deficiency anaemia in the same group (p < 0.05). The IgG responses to all the three malaria specific antigens were low among children without malaria episode but high among those with two and four episodes due to exposure differences. CONCLUSION:Iron fortification did not influence antibody response against endogenous malaria specific antigens among pre-school children in malaria endemic areas, however, IgG response to malaria specific antigens were high among children with sufficient iron status.
Authors: Issa Nebie; Amidou Diarra; Alphonse Ouedraogo; Issiaka Soulama; Edith C Bougouma; Alfred B Tiono; Amadou T Konate; Roma Chilengi; Michael Theisen; Daniel Dodoo; Ed Remarque; Samuel Bosomprah; Paul Milligan; Sodiomon B Sirima Journal: Infect Immun Date: 2007-12-10 Impact factor: 3.441
Authors: Mark Kaddumukasa; Catherine Lwanira; Allan Lugaajju; Elly Katabira; Kristina E M Persson; Mats Wahlgren; Fred Kironde Journal: PLoS One Date: 2015-04-23 Impact factor: 3.240
Authors: Joe N Frost; Tiong Kit Tan; Munawar Abbas; Sarah K Wideman; Michael Bonadonna; Nicole U Stoffel; Katherine Wray; Barbara Kronsteiner; Gaby Smits; Dean R Campagna; Tiago L Duarte; José M Lopes; Akshay Shah; Andrew E Armitage; João Arezes; Pei Jin Lim; Alexandra E Preston; David Ahern; Megan Teh; Caitlin Naylor; Mariolina Salio; Uzi Gileadi; Simon C Andrews; Susanna J Dunachie; Michael B Zimmermann; Fiona R M van der Klis; Vincenzo Cerundolo; Oliver Bannard; Simon J Draper; Alain R M Townsend; Bruno Galy; Mark D Fleming; Marie C Lewis; Hal Drakesmith Journal: Med (N Y) Date: 2021-02-12
Authors: Daniel Dodoo; Anastasia Aikins; Kwadwo Asamoah Kusi; Helena Lamptey; Ed Remarque; Paul Milligan; Samuel Bosomprah; Roma Chilengi; Yaa Difie Osei; Bartholomew Dicky Akanmori; Michael Theisen Journal: Malar J Date: 2008-07-29 Impact factor: 2.979
Authors: Priyanka Barua; Upeksha P Chandrasiri; James G Beeson; Kathryn G Dewey; Kenneth Maleta; Per Ashorn; Stephen J Rogerson Journal: Malar J Date: 2018-02-07 Impact factor: 2.979